Acidum succinicum intermedium (2R, 3R) -2,3-bis [(4-methylbenzoyl) oxy] succinicum ac (3R, 4R)- N, 4-dimethyl-1- (phenylmethyl) -3-piperidini aminei CAS No. -71-8

Intermedia nostra tofacitinib sunt critica in processu fabricando de tofacitinib, noto medicamento adhibito ad quasdam species arthritis tractandas.Hoc medium agit munus vitalis in productione tofacitinib, ad suam efficaciam et qualitatem conferens.Via (2R,3R)-2,3-bis[(4-methylbenzoyl)oxy] acidum succinicum et (3R,4R)-N,4-dimethyl-1-(phenylmethyl)- Coniunctio praecisa 3-piperidinaminum, nostri producto efficit synthesim optimae qualitatis tofacitinib quae industriae signa obviat et excedit.

Formula hypothetica et pondus nostrae tofacitinib intermediam suam puritatem et potentiam demonstrant, efficiens ut certa pars processus fabricationis pharmaceuticae.Cum suis medicamentis accurate mensuratis, hoc medium praestat constantiam et efficaciam ultimi producti, tofacitinib.Eius proprietates hypotheticae etiam ad altiorem stabilitatem et fasciae vitam conferunt, ut efficax et certa per longum tempus permanet.